SUMMARY
Our present study aimed to investigate the effect of lentiviral-mediated RNAi using shRNA targeting Smad4 on TGF-beta1 induced fibrosis. shRNAs targeting Smad4 were designed and the most efficient shRNA was screened. This shRNA was introduced into a lentiviral vector which was used to infect C2C12 myoblasts, and then the Smad4 expression was detected. Cells were divided into: C2C12 cells group, TGF-beta1 induction group, transfection group, and transfection after TGF-beta1 induction group. C2C12 myoblasts were transfected with lentivirus carrying Smad4-shRNA and treated with TGF-beta1 to induce the differentiation into myofibroblasts. Fluorescence real-time-PCR and the western blot assay were employed to detect the expressions of collagen I and alpha-SMA. The results showed that the protein and mRNA expression of Smad4 in the C2C12 cells transfected with Smad4-shRNA1 was significantly reduced when compared with C2C12 before transfection. In the TGF-beta1 induction group, the mRNA expressions of alpha-SMA and collagen I were significantly increased as compared to the C2C12 cells group. In the transfection after TGF-beta1 induction group, the mRNA expressions of alpha-SMA and collagen I were significantly increased compared to the transfection group, and the protein expressions significantly increased, respectively. In the transfection after TGF-beta1 induction group, the mRNA expressions of alpha-SMA and collagen I were significantly decreased compared to the TGF-beta1 induction group, and the protein expressions significantly reduced, respectively. The results indicate that suppression of Smad4 expression can efficiently inhibit the TGF-beta1 induced fibrosis in myoblasts. The findings suggest Smad4 may become a novel target for the treatment of skeletal muscle fibrosis.
KEY WORDS
skeletal muscle injury; fibrosis; transforming growth factor-beta1; C2C12 myoblast
REFERENCES
Bran GM, Sommer UJ, Goessler UR, Hormann K, Riedel F and Sadick H. TGF-ss1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. Anticancer Res. 30: 3459-3463, 2010.
[PubMed]
Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 84: 209-238, 2004.
[CrossRef]
[PubMed]
Cheng J, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood). 227: 943-956, 2002.
Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (Soccer). Am J Sports Med. 39: 1226-1232, 2011.
[CrossRef]
[PubMed]
Ghosh AK, Yuan W, Mori Y, Chen S, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem. 276: 11041-11048, 2001.
[CrossRef]
[PubMed]
Gressner OA. Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology. 50: 970-978, 2009.
[CrossRef]
[PubMed]
Jackson WM, Aragon AB, Onodera J, Steven M, Koehler SM, Ji Y, Bulken-Hoover JD, Vogler JA, Tuan RS, Nesti LJ. Cytokine expression in muscle following traumatic injury. J Orthop Res. 29: 1613-1620, 2011.
[CrossRef]
[PubMed]
Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J, Klippel A. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Oncogene. 22: 6748-6763, 2003.
[CrossRef]
[PubMed]
Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 18: 816-827, 2004.
[CrossRef]
[PubMed]
Li J, Tang X, Chen X. Comparative effects of TGF-beta2/Smad2 and TGF-beta2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. Exp Eye Res. 92: 173-179, 2011.
[CrossRef]
[PubMed]
Li TT, Si GM, Chen FC. Effects of Shenqi Jiedu Decoction on expressions of transforming growth factor-beta1, smad2 and smad3 in renal tissues of rats with chronic renal failure induced by adenine. Zhong Xi Yi Jie He Xue Bao. 8: 263-268, 2010.
[CrossRef]
[PubMed]
Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 161: 895-907, 2002.
[CrossRef]
Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 164: 1007-1019, 2004.
[CrossRef]
Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci. 14: 2923-2934, 2009.
[CrossRef]
[PubMed]
Musaro A. Growth factor enhancement of muscle regeneration: a central role of IGF-1. Arch Ital Biol. 143: 243-248, 2005.
[PubMed]
Nishikawa Y, Sugiyama T. A shRNA library constructed through the generation of loop-stem-loop DNA. J Gene Med. 12: 927-933, 2010.
[CrossRef]
Ono Y, Sensui H, Okutsu S, Nagatomi R. Notch2 negatively regulates myofibroblastic differentiation of myoblasts. J Cell Physiol. 210: 358-369, 2007.
[CrossRef]
[PubMed]
Orchard JW. Intrinsic and extrinsic risk factors for muscle strains in Australian football. Am J Sports Med. 29: 300-303, 2001.
[PubMed]
Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 277: C1-9, 1999.
[PubMed]
Tse R, Howard J, Wu Y, Gan BS. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2. BMC Musculoskelet Disord. 5: 41, 2004.
[CrossRef]
[PubMed]
Urish K, Kanda Y, Huard J. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration. Curr Top Dev Biol. 68: 263-280, 2005.
[CrossRef]
Wagers AJ, Conboy IM. Cellular and molecular signatures of muscle regeneration. current concepts and controversies in adult myogenesis. Cell. 122: 659-667, 2005.
[CrossRef]
[PubMed]
Wang Z, Gao Z, Shi Y, Sun Y, Lin Z, Jiang H, Hou T, Wang Q, Yuan X, Zhu X, Wu H, Jin Y. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg. 60: 1193-1199, 2007.
[CrossRef]
Wicik Z, Sadkowski T, Jank M, Motyl T. Transcriptional pattern of TGF-beta1 inhibitory effect on mouse C2C12 myoblasts differentiation. Pol J Vet Sci. 13: 629-638, 2010.
[CrossRef]
[PubMed]
Zhu X, Topouzis S, Liang LF, Stotish RL. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine. 26: 262-272, 2004.
[CrossRef]
[PubMed]
|
CITED
0
|
